GHRP-2 – 5mg

GHRP-2 (Growth Hormone-Releasing Peptide-2)—also known as Pralmorelin—is a highly potent, synthetic second-generation growth hormone secretagogue. It belongs to the class of small peptide molecules that act directly on both the hypothalamus and the anterior pituitary gland to stimulate growth hormone (GH) release. As a synthetic ghrelin receptor agonist, GHRP-2 is widely utilized in endocrine research to map growth hormone axis dynamics and evaluate systemic metabolic signaling cascades.

Key Features & Characteristics

• Mechanism of Action: Binds selectively to the growth hormone secretagogue receptor (GHS-R), acting as a direct mimetic of the endogenous hormone ghrelin.
• Pituitary Activation: Triggers a robust, pulsatile release of endogenous growth hormone via a calcium-dependent intracellular signaling pathway.
• Appetite Modulation: Exhibits mild-to-moderate activation of central hunger pathways, though less intensely than first-generation counterparts like GHRP-6.
• Physical Form: Synthesized to strict analytical thresholds and supplied as a sterile, white lyophilized powder requiring precise laboratory reconstitution.

Primary Research Applications

• Somatotropic Axis Evaluation: Extensively studied in animal models to understand the feedback mechanisms, ceiling effects, and pulse amplitudes of growth hormone secretion.
• Anabolic & Musculoskeletal Kinetics: Investigated for its downstream capability to elevate systemic Insulin-like Growth Factor 1 (IGF-1), influencing nitrogen retention and muscle mass regulation.
• Cardioprotection & Tissue Repair: Evaluated for its potential to protect myocardial cells against ischemic injury and accelerate cellular repair mechanisms following tissue damage.

For Research Use Only. Not for human consumption, therapeutic, or diagnostic use.